Bon Secours Hampton Roads Health System and Sentara Healthcare Reaching Out to Recent Patients
Norfolk, Va. (Oct. 22, 2012) — Bon Secours Virginia Health System and Sentara Healthcare are notifying patients of medications they received during recent treatment or surgery if the injected drugs were purchased from the New England Compounding Center (NECC) - a pharmacy under investigation for a national outbreak of infections linked to tainted drugs.
While the Hampton Roads health systems did not have any patients treated with the tainted steroids, out of an abundance of caution, the providers are proactively notifying all patients who have received any NECC injectable drugs between May 21, and October 4, 2012 in response to FDA concerns.
Health system officials emphasize that the drugs these patients received have not currently been confirmed to cause infections and that any drugs from the NECC were immediately removed from the health systems’ inventory.
Authorities say the risk is very low and they do not believe that anyone will become ill because of these drugs. If a patient’s procedure occurred more than four weeks ago, it is unlikely there is any cause for concern. It is also unlikely there is a risk of meningitis unless the injection was near or on your spine or joint.
If a patient received injectable NECC drugs during a recent treatment or surgery and is experiencing symptoms such as fever, nausea, increased pain at incision, redness/drainage around incision, the health systems recommend the patient contact their physician immediately. Both health systems have established call centers to help answer questions or concerns at: Bon Secours 757-889-2273(CARE) or Sentara 1-800-SENTARA(1-800-736-8272).
Other states receiving contaminated medication include Florida, Idaho, Illinois, Indiana, Maryland, Michigan, Minnesota, New Hampshire, New Jersey, North Carolina, Ohio, Pennsylvania, Tennessee and Texas. For more information, visit www.fda.gov, or www.cdc.gov.
Bon Secours Virginia Health System
For more health information and the latest news, visit Sentara News or follow us on Facebook and Twitter.